Less Ads, More Data, More Tools Register for FREE

Pin to quick picksN4 Pharma Plc Regulatory News (N4P)

  • There is currently no data for N4P

New Solar Installation

16 Oct 2012 07:00

RNS Number : 7030O
Ultima Networks PLC
16 October 2012
 



16 October 2012

 

ULTIMA NETWORKS PLC

("Ultima" or the "Company") 

 

 

New Solar Installation

 

The Board of Ultima, the AIM listed IT and Green Technology Company, is pleased to announce that its Green Technology Division has won an Engineering, Procurement and Construction (EPC) contract to install a 150kw Solar PV installation from MJ & SC Collins, a local farm in Essex.

 

The installation will be situated on five farm buildings and will power the various industrial units needed to run the 3,000 acre arable farm, such as crop drying. It is expected to be completed by end of October 2012.

 

Prof. Humayun Mughal, Chairman and CEO of Ultima, commented, "What is particularly exciting about this new installation is that the farmer is paying for the cost himself for the sake of environment, rather than treating it as a business investment. He is a dedicated environmentalist and is keen to pioneer alternative solutions to meet the energy needs of his business. I am also pleased to say that this order will take Ultima's total PV installed base in the UK to over 1.1MW."

 

Simon Collins, Managing Director of MJ & SC Collins of Harlow said, "As a farmer and guardian of the local countryside, I am keen to pursue environmentally responsible methods for running my operations and this includes the use of solar energy to replace traditional sources of electricity."

 

-ends-

 

 

Enquiries:

 

Ultima Networks plc 01279 821200

Prof. Humayun Mughal, Chairman and Chief Executive

 

Zeus Capital Limited (Nominated Adviser and Broker) 0161 831 1512

Nick Cowles

Imran Ahmad

 

Leander (Financial PR) 07795 168157

Christian Taylor-Wilkinson

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUVSARUUARAAA
Date   Source Headline
17th Mar 202612:14 pmRNSResult of General Meeting and Change of Name
27th Feb 20267:00 amRNSNotice of GM and Proposed Change of Name
24th Feb 20267:00 amRNSCEO Appointment & Name Change Thalia Therapeutics
17th Dec 20257:00 amRNSBusiness and Operational Update
25th Sep 20257:00 amRNSInterim Results
23rd Sep 20257:00 amRNSPartnership with University of Strathclyde’s CMAC
22nd Sep 20257:00 amRNSN4 Pharma’s Nuvec® Targets Lung Cancer Cells
19th Sep 20257:00 amRNSNotice of Results, Analyst & Investor Presentation
11th Sep 20257:00 amRNS-RInvestor Event and Presentation
30th Jul 20251:55 pmRNS-RArticle on Nuvec®’s Potential in RNA Therapeutics
14th Jul 20257:00 amRNS-RInvestor Webinar
8th Jul 20257:00 amRNSDirectorate Change
30th Jun 20252:15 pmRNSResult of AGM
30th Jun 20257:00 amRNSAGM Statement
25th Jun 20257:00 amRNS-RInsight Event for Retail Investors
6th Jun 20257:00 amRNSFinal Results, Annual Report and Notice of AGM
27th May 20257:00 amRNS-REstablishment of New Senior Leadership Team
23rd May 202512:37 pmRNSTR-1: Notification of major holdings
21st May 20254:11 pmRNSHolding(s) in Company
15th May 20253:13 pmRNSChange of Registered Address
12th May 20257:00 amRNSN4 101 In Vivo Study Results
9th May 20258:24 amRNSHolding(s) in Company
29th Apr 20254:25 pmRNSHolding(s) in Company
29th Apr 202511:05 amRNSHolding(s) in Company
28th Apr 20252:30 pmRNSHolding(s) in Company
23rd Apr 20252:32 pmRNSTR-1: Standard form notification of major holdings
22nd Apr 202511:56 amRNSResult of General Meeting
4th Apr 20257:08 amRNSPosting of Circular and Notice of General Meeting
1st Apr 20254:08 pmRNSPlacing and Subscription to raise £1,750,000
18th Feb 202512:34 pmRNSHolding(s) in Company
7th Feb 20257:00 amRNS-RInvestor Webinar
27th Jan 20257:00 amRNS-RInvestor Webinar
16th Jan 20257:00 amRNS-RN4 Pharma Non-Executive Director Q&A
8th Jan 20257:00 amRNSDirectorate Changes
12th Dec 20247:00 amRNSN4 101 In Vitro Results
4th Dec 20247:00 amRNSNew Patent Filing
28th Nov 20247:00 amRNSGrant of Options
24th Sep 20247:00 amRNSInterim Results
17th Sep 20248:04 amRNSSRI Research Update
9th Sep 20247:00 amRNSDirector Appointment
23rd Aug 20248:30 amRNSChange of Auditor
20th Aug 20247:00 amRNSSRI Research Update
3rd Jul 20247:00 amRNSNanogenics Update
28th Jun 20247:00 amRNSTotal Voting Rights
19th Jun 20247:00 amRNSHolding(s) in Company
18th Jun 202412:34 pmRNSHolding(s) in Company
13th Jun 20244:52 pmRNSHolding(s) in Company
11th Jun 202411:16 amRNSNew Corporate Presentation
7th Jun 202410:18 amRNSPlacing and Subscription to raise £630,000
23rd May 20244:09 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.